SCHEMBL3659751

SCHEMBL3659751

C#CCCCCCOc1cccc(NC)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
SLC6A4 P31645 2/20 0.35
PTPN1 P18031 1/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 2/20 0.34
ALOX15 P16050 1/20 0.34
MAOA P21397 2/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HRH1 P35367 1/20 0.33
HTR1A P08908 1/20 0.32
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
APP P05067 1/20 0.32
MAOB P27338 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664516 1.00 EGFR (0.35) EGFRL3MBTL1TDP1SLC6A4PTPN1
SCHEMBL3662259 0.99 L3MBTL1 (0.36) EGFRL3MBTL1TDP1SLC6A4PTPN1
SCHEMBL3660251 0.94 EGFR (0.34) EGFRL3MBTL1TDP1SLC6A4PTPN1
Hydrochloric Acid SCHEMBL3663052 0.93 EGFR (0.34) EGFRL3MBTL1TDP1SLC6A4PTPN1
SCHEMBL3662356 0.90 APP (0.34) L3MBTL1TDP1SLC6A4MAOAHDAC1
SCHEMBL3661499 0.85 L3MBTL1 (0.34) L3MBTL1TDP1SLC6A4PTPN1ALDH1A1
SCHEMBL3660239 0.83 L3MBTL1 (0.35) L3MBTL1TDP1SLC6A4PTPN1CYP3A4
SCHEMBL3659801 0.82 L3MBTL1 (0.37) L3MBTL1TDP1SLC6A4PTPN1CYP3A4
SCHEMBL3662005 0.81 MAPT (0.41) CYP3A4MAOAHTR1AAPPMAOB
SCHEMBL3664404 0.79 SMN1; SMN2 (0.34) L3MBTL1TDP1SLC6A4PTPN1HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed
EP-2215062-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME Sumitomo Chemical Company, Limited (JP) 2010-08-11 EP disclosed
WO-2009069792-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 EGFR 1901/4885L3MBTL1 40/4885TDP1 4310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.